Article Impact Level: HIGH Data Quality: STRONG Summary of Haematologica. https://doi.org/10.3324/haematol.2024.287061 Dr. Antonia Schäfer et al.
Points
- Researchers analyzed 1,247 donor-recipient pairs to investigate how donor KIR gene polymorphisms affect the success of hematopoietic stem cell transplantation for patients with blood cancer.
- The study identified that a specific KIR2DS4*00101 interaction with the recipient’s HLA molecules significantly worsened patient survival and increased transplant-related mortality.
- Specific strong KIR2DL2/L3 interactions with the HLA-C1 ligand were found to substantially increase the incidence of chronic graft-versus-host disease in transplant recipients.
- A protective effect was observed, as highly inhibiting KIR3DL1 interactions with HLA-Bw4 were strongly associated with a reduced incidence of cancer relapse following transplantation.
- The findings support the integration of high-resolution KIR genotyping into the donor selection process to maximize compatibility and enhance overall patient survival rates.
Summary
Researchers investigated the impact of high-resolution donor killer cell immunoglobulin-like receptor (KIR) allelic polymorphism on hematopoietic stem cell transplantation (HSCT) outcomes. Addressing a gap in existing literature, this study analyzed a national cohort of 1247 HLA-matched donor/recipient (D/R) pairs using Cox proportional hazards models to determine the influence of specific KIR gene interactions on post-transplant success. The primary aim was to move beyond KIR gene presence/absence analysis to understand the clinical relevance of specific alleles.
The multivariable analysis revealed that D/R pairs with a KIR2DS400101 – HLA-C1/C2/A11 interaction demonstrated a significant detrimental impact on progression-free survival (PFS), overall survival (OS), transplant-related mortality (TRM), and chronic graft-versus-host disease (cGvHD). Additionally, strong KIR2DL2/L3–HLA–C1 interactions, particularly involving alleles KIR2DL300501 and *015, were associated with a significant increase in the incidence of cGvHD when compared to D/R pairs missing the ligand.
Conversely, a protective effect was observed, where highly inhibiting KIR3DL1–HLA–B and HLA-A (Bw4) interactions were associated with a reduced relapse incidence compared to weak or non-inhibiting interactions. These findings from the cohort of 1,247 pairs indicate that high-resolution KIR genotyping provides critical information for predicting post-transplant outcomes. The authors conclude that this level of genetic detail should be systematically incorporated into donor selection to improve patient survival, suggesting a higher protective capacity of educated natural killer (NK) cells.
Link to the article: https://haematologica.org/article/view/12166
References Schäfer, A., Buhler, S., Farias, T. D. J., Kichula, K. M., Baldomero, H., Sollet, Z. C., Ferrari-Lacraz, S., Micheli, B., Masouridi-Levrat, S., Mesquita, V., Kürsteiner, O., Nair, G., Halter, J., Güngör, T., Schneidawind, D., Chalandon, Y., Passweg, J. R., Norman, P. J., & Villard, J. (2025). Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation. Haematologica. https://doi.org/10.3324/haematol.2024.287061
